Technology
The biggest opportunity to improve lung cancer survival isn’t a new drug
Chris Wood, CEO of RevealDx, discusses the role of AI-based characterization of lung nodules (CADx) in improving lung cancer survival outcomes. The commentary positions software-based diagnostic tools as a key opportunity in the clinical workflow rather than pharmaceutical innovation alone.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network